OTCPK:MEDVF - Post by User
Post by
WinterBaronon Jun 17, 2020 10:42am
93 Views
Post# 31159882
Submit Questions to Management for Webinar
Submit Questions to Management for WebinarThe following are among questions submitted to Questcap for management to address during the webinar today at 4:00 PM.
Anyone who has specific concerns or questions for the company is encouraged to use the contact info. provided.
" Thank you for registering for "QuestCap Corporate Update Webinar".
Please submit any questions to: Nikolas.Matysek@questcapinc.com
Considering the importance to shareholders of an understanding regarding the manner in which the company determines the use of publicly raised funds and compensation of those directly benefitting from resources at the company, it is important that management ensures responses are clear and precise.
1.)
It is difficult to accept that Questcap is paying the equivalent of 2.22 Million Dollars for only a 30% interest in Glenco Medical.
That company has declared it is "Pre-Revenue" (I.e. no appreciable sales)
and
No documentation has been provided to inform shareholders of Glenco’s revenue forecast, general business model or profitability prospects.
How has valuation been determined?
2.)
Why has Questcap not earned a significantly higher ownership position in Glenco Medical?
Does the Glenco Medical Balance Sheet indicate asset value exceeds liabilities by 6 million Dollars
or
Is valuation based upon "Goodwill"?
Note: Comment in italics were inserted after the questions were submitted for the webinar.
The 6 Million Figure must be considered with context.
If a 30% Interest in the company = 2.22 mill. Then 100/30 x 2.22 = 7.4 Million.
Therefore the 6 Million asset value allows for a Goodwill Factor to Dr. Copeland.
3.)
Why has the company sought "Safe Harbor" protection?
Is there some aspect of the declared information deemed to be questionable or mis-leading?
Or
Are there considerations for future re-alignment or re-purchase of the shares being issued?